Owens & Minor (OMI)
(Delayed Data from NYSE)
$16.48 USD
+1.17 (7.64%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $16.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.48 USD
+1.17 (7.64%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $16.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Buy These 5 Low-Beta Stocks to Beat the Choppy Market
by Nilanjan Banerjee
To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.
NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout
by Zacks Equity Research
NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.
Owens & Minor (OMI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 32.56% and 8.97%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.
Owens & Minor (OMI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Owens & Minor (OMI) closed at $27.37, marking a +0.11% move from the previous day.
Why the Earnings Surprise Streak Could Continue for Owens & Minor (OMI)
by Zacks Equity Research
Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Owens & Minor (OMI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Owens & Minor (OMI) closed the most recent trading day at $29.08, moving -1.79% from the previous trading session.
Owens & Minor (OMI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Owens & Minor (OMI) closed at $26.97 in the latest trading session, marking a +0.33% move from the prior day.
Top Ranked Growth Stocks to Buy for January 13th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 13th.
Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+
by Zacks Equity Research
Neogen's (NEOG) new test can detect cancer causing aflatoxin M1 in milk within a range of 150-600 parts per trillion (ppt).
Top Ranked Growth Stocks to Buy for January 12th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 12th.
Top Ranked Growth Stocks to Buy for January 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 11th
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Owens & Minor and Lakeland Industries
by Zacks Equity Research
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Owens & Minor and Lakeland Industries
Stryker (SYK) Buys OrthoSensor to Grow in Sensor Technology
by Zacks Equity Research
Stryker's (SYK) acquisition of OrthoSensor will help surgeons with real-time data-driven solutions and improve patient outcomes.
Buy These 5 Low-Beta Stocks to Combat the Choppy Market
by Nilanjan Banerjee
Low-beta stocks may be able to help sail through the choppy market conditions.
Allscripts (MDRX) Completes Sale of CarePort Health Business
by Zacks Equity Research
Allscripts' (MDRX) agreement with WellSky empowers providers with efficient care transitions and better patient health outcomes.
Top Ranked Growth Stocks to Buy for January 5th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 5th
Top Ranked Growth Stocks to Buy for December 30th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 30th.
Medtronic (MDT) MITG Shows Fast Recovery Amid COVID-19 Woes
by Zacks Equity Research
Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.
5 Soaring MedTech Stocks to Buy for More Growth in 2021
by Urmimala Biswas
We have selected five MedTech growth stocks with further rooms for improvement in 2021.
Zacks.com featured highlights include: Vista, Innoviva, Owens & Minor, NIC and California Water Service
by Zacks Equity Research
Zacks.com featured highlights include: Vista, Innoviva, Owens & Minor, NIC and California Water Service
Combat the Choppy Market With These 5 Low-Beta Stocks
by Nilanjan Banerjee
To combat market volatility, create a portfolio of low-beta stocks.
Top Ranked Growth Stocks to Buy for December 24th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 24th.
5 Finest GARP Stocks Based on Discounted PEG
by Urmimala Biswas
Here we discuss five GARP stocks, TAP, OMI, TD, MCK and HMC, which while trading cheap at this moment, are generating robust growth rates on strong fundamentals.
Zacks.com featured highlights include: Hain, Owens & Minor, Myers, Owens and ManpowerGroup
by Zacks Equity Research
Zacks.com featured highlights include: Hain, Owens & Minor, Myers, Owens and ManpowerGroup